Movicol and Hypomagnesaemia - a phase IV clinical study of FDA data
Summary:
Hypomagnesaemia is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dexamethasone, and have Small cell lung cancer extensive stage.
The phase IV clinical study analyzes which people have Hypomagnesaemia when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
What is Hypomagnesaemia?
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood) is found to be associated with 1,028 drugs and 1,056 conditions by eHealthMe. Check the latest studies of Hypomagnesaemia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14,199 people reported to have side effects when taking Movicol.
Among them, 58 people (0.41%) have Hypomagnesaemia.

Among these 58 people:
How long have people been on Movicol when they have Hypomagnesaemia? *
- < 1 month: 88.89 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 11.11 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hypomagnesaemia when taking Movicol? *
- female: 56.36 %
- male: 43.64 %
What is the age of people who have Hypomagnesaemia when taking Movicol? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 5.45 %
- 40-49: 5.45 %
- 50-59: 3.64 %
- 60+: 85.45 %
What are other drugs people take besides Movicol? *
- Etoposide: 23 people, 39.66%
- Carboplatin: 23 people, 39.66%
- Dexamethasone: 23 people, 39.66%
- Clopidogrel: 17 people, 29.31%
- Acetaminophen: 17 people, 29.31%
- Palonosetron: 16 people, 27.59%
- Acetylcysteine: 12 people, 20.69%
- Ventolin: 12 people, 20.69%
- Furosemide: 12 people, 20.69%
- Ondansetron: 11 people, 18.97%
What are other side effects people have besides Hypomagnesaemia? *
- Hypokalemia (low potassium): 22 people, 37.93%
- Thrombocytopenia (decrease of platelets in blood): 21 people, 36.21%
- Anaemia (lack of blood): 21 people, 36.21%
- Aspartate Aminotransferase Increased: 20 people, 34.48%
- Nausea (feeling of having an urge to vomit): 17 people, 29.31%
- Weakness: 17 people, 29.31%
- Dyspnea (difficult or laboured breathing): 15 people, 25.86%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 15 people, 25.86%
- Nosebleed (bleeding from nose): 14 people, 24.14%
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 13 people, 22.41%
What are the existing conditions these people have? *
- Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 31 people, 53.45%
- High Blood Pressure: 11 people, 18.97%
- Neoplasm Malignant (cancer tumour): 9 people, 15.52%
- Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 6 people, 10.34%
- Sedation: 6 people, 10.34%
- Adverse Event: 6 people, 10.34%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.34%
- Oesophagitis (inflammation of oesophagus): 6 people, 10.34%
- Urinary Tract Infection: 5 people, 8.62%
- Dyslipidaemia (abnormal amount of lipids): 5 people, 8.62%
* Approximation only. Some reports may have incomplete information.
Do you take Movicol and have Hypomagnesaemia?
- Check whether Hypomagnesaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Movicol:
- Movicol (14,249 reports)
Hypomagnesaemia treatments and more:
- Hypomagnesaemia (18,707 reports)
How severe was Hypomagnesaemia and when was it recovered:
Expand to all the drugs that have ingredients of polyethylene glycol 3350:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypomagnesaemia:
- Hypomagnesaemia (1,028 drugs)
Browse all the conditions that are associated with Hypomagnesaemia:
- Hypomagnesaemia (1,056 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Farxiga vs. Novolog Flexpen, side effect and effectiveness comparison - 11 seconds ago
- How effective is Cetirizine Hydrochloride Allergy for Allergic Sinusitis? - 15 seconds ago
- Could Mounjaro cause Blister? - a minute ago
- Could Nexium cause Xerosis? - a minute ago
- Could Methylene Blue cause Hyperreflexia? - a minute ago
- Could Fentanyl cause Blood Ph Increased? - a minute ago
- Could Zithromax cause Gestational Diabetes? - a minute ago
- Could Spravato cause Derealisation? - a minute ago
- Zimovane vs. Beldin, side effect and effectiveness comparison - a minute ago
- Could Ketoconazole cause Abscess Limb? - a minute ago